http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2107910-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_502f26e8457a04ae8ec1f9fc7adfd85d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 1993-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b43b6433eaffb604ad89215ddfec47 |
| publicationDate | 1998-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2107910-C1 |
| titleOfInvention | Method for treating cardiac ischemia disease |
| abstract | FIELD: medicine. SUBSTANCE: method involves additionally administering aspirin and Aevit in addition to combined helium-neon laser therapy and medical drug treatment, daily during the whole treatment course. Antithrombin III value (AT III) and the level of general antioxidation activity in blood are controlled (before and after helium-neon laser therapy). The value of AT III being lowered with respect to norm, helium-neon laser therapy is applied each second-third day and every day in other cases. Maximum values of antioxidation activity being stabilized, intravenous injections are finished and skin procedures are started. The procedures are applied every day or every second day during 30-45 s on each stimulation zone. EFFECT: enhanced effectiveness of treatment. |
| priorityDate | 1993-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.